Skip to content

Terran Biosciences Announces Acquisition of a Portfolio of Novel CNS Therapeutics from Concert Pharmaceuticals

By asianet

Terran Biosciences (“Terran”), a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric diseases, has entered into an agreement with Concert Pharmaceuticals (“Concert”) to acquire a portfolio of Concert’s CNS therapeutics and accompanying intellectual property. Logo – https://mma.prnewswire.com/media/1758607/terran_biosciences_Logo.jpg These deuterated compounds represent next-generation therapeutics with applications across several different psychiatric … Continued

Angel Yeast Steps Up Low-Carbon Measures in Green Push to Promote Global Sustainable Development

By asianet

Angel Yeast Co., Ltd(http://en.angelyeast.com/) (“Angel Yeast” or “the Company”, 600298.SH), a listed global yeast and yeast extract manufacturer, has reached another recognition milestone for its green push towards the goal of carbon-neutrality after China’s Ministry of Industry and Information Technology recently named Angel Yeast as one of the national “Green Factories.” The recognition is testimony … Continued

Novavax Announces Launch of Global Vaccine Education Programs

By asianet

– ‘We Do Vaccines’ and ‘Know Our Vax’ are new educational efforts that provide information regarding vaccines – Programs explain Novavax’ commitment to vaccine development and innovation Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the launch of its global unbranded ‘We Do … Continued

Gan & Lee Pharmaceuticals Begins First-In-Human Trial in U.S. for Investigational Drug, GZR18

By asianet

Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), is pleased to announce the first subject has been dosed in our Phase I, double-blinded, randomized, placebo-controlled, sequential, single, ascending dose clinical study in the U.S. for the company’s investigational drug, GZR18. GZR18 is a glucagon-like peptide-1 receptor agonist … Continued

FS-ISAC Report Finds Global Cyber Threats Accelerate as Cybercriminals and Nation-State Actors Converge and Collaborate

By asianet

— Third-party risk, zero-day vulnerability exploits, and ransomware will remain at the forefront of the cyber threats facing financial institutions in 2022 FS-ISAC ( https://c212.net/c/link/?t=0&l=en&o=3467853-1&h=76173043&u=https%3A%2F%2Fwww.fsisac.com%2F&a=FS-ISAC ), the only global cyber intelligence sharing community solely focused on financial services, today announced the findings of its annual Global Intelligence Office report, Navigating Cyber 2022 ( https://c212.net/c/link/?t=0&l=en&o=3467853-1&h=4182962358&u=https%3A%2F%2Fwww.fsisac.com%2Fnavigatingcyber2022-report%3Futm_campaign%3D2022-GIOReport%26utm_source%3Dmedia%26utm_medium%3DPressRelease&a=Navigating+Cyber+2022 ). … Continued

Global Beer Brand, Corona, Appoints Renowned Design, Culinary and Lifestyle Experts to Develop Corona Island

By asianet

— Chef Christopher Carpentier, Native Colombian and Lifestyle Aficionado Paulina Vega and International Architecture Firm, James + Mau, join Corona’s Mission to Protect Paradise In advance of the highly anticipated opening of Corona Island ( https://c212.net/c/link/?t=0&l=en&o=3469182-1&h=2370929469&u=http%3A%2F%2Fwww.livecoronaisland.com%2F&a=Corona+Island ), a destination designed to help visitors disconnect from the everyday and reconnect with the natural world, Corona announced … Continued

“Carbon Neutrality” Creates New Era | What Dr. Fang saw at MWC?

By asianet

The 2022 Mobile World Congress (MWC) which attracted more than 2000 companies’ participation was successfully held in Barcelona from February 28th to March 3rd. As the world’s top mobile congress, MWC 2022 focused on hot topics such as 5G, AI, cloud network and the Internet of Everything. MWC2022 turn out be the first underline exhibition … Continued